{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP05199",
    "Peptide Name": "Z2 (Synthetic AMPs, Ile-rich, Arg-rich, UCLL1; BBN; Z1, MIC>64 ug/ml)",
    "Source": "De novo designed, man-made sequences",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "RKIIRRIIPIIRRIIKR",
    "Sequence Length": 17,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 8,
    "Boman Index": 3.6,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "47%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar to (58.82%) todesigned GNU6I: 47%, R: 35%, K: 12%.Activity: active against 4 strains E. coli ATCC 9637 or SYP-B3820/B4288/B4289 (MIC 2-8 ug/ml), 3 strains A. baumannii SYP-B4290/B4291/B3819 (MIC 4-8 ug/ml), S. paratyphi ATCC 14028 (MIC 4 ug/ml), K. pneumoniae CMCC46117 (MIC 4 ug/ml), and P. aeruginosa ATCC 9027 (MIC 4 ug/ml).Warning: only Gram- bacteria were tested.Structure: more helical in SDS than in TFE.In vitro toxicity: 0.14% hemolysis at 128 ug/ml, HC50>100 ug/ml, poorly hemo.lytic.Antimicrobial robustness: NaCl-insensitive:P. aeruginosa, KCl-insensitive:P. aeruginosa, MgCl2-insensitive:P. aeruginosa, FeCl3-insensitive:P. aeruginosa, NH4Cl-insensitive:P. aeruginosa, CaCl2-insensitive:P. aeruginosa,   serum-insensitive (50%).Peptide stability:  cleaved by trypsin, cleaved by chymotrypsin.",
    "Author": "Zhang MY, Li S, Han YL, Shi YF, Wu YY, Cheng J, Wang CY, Zhou XY, Zhang YX. 2025",
    "Reference": "Bioorg Chem. 2025 Feb 22;157:108309. doi: 10.1016/j.bioorg.2025.108309.PubMed",
    "Title": "De novo-designed amphiphilic alpha-helical peptide Z2 exhibits broad-spectrum antimicrobial, anti-biofilm, and anti-inflammatory efficacy in acute Pseudomonas aeruginosa pneumonia."
  },
  "3D Structure": []
}